Sell closed pharmaceutical plant systems through IPP’s global buyer network

Sell closed pharmaceutical plant sites and equipment through IPP, the trusted source for global resale of process facilities.

When your pharmaceutical plant closes, IPP helps you exit quickly, profitably, and without the headaches

Selling a closed pharmaceutical plant requires speed, discretion, and technical know-how. International Process Plants (IPP) has more than 47 years of experience helping pharma companies divest shuttered manufacturing sites safely and efficiently. We provide a full-service model — from valuation and marketing to buyer matchmaking, asset removal, and optional remediation.

IPP manages over 20 complete plant sites and maintains a massive inventory of used and surplus process plants, including live listings of pharma-grade systems in our online inventory. Whether your plant was closed recently or mothballed for years, we help you convert idle assets into working capital and opportunity.

What sets IPP apart in pharmaceutical plant sales  

Pharmaceutical facilities come with strict regulatory requirements and specialized equipment. Our team understands cGMP compliance, cleanroom standards, and the resale value of stainless steel, glass-lined, and specialty alloy systems.

We manage every detail — including teardown, rigging, utility disconnection, and transportation — and we ensure that buyers meet your asset’s technical, regulatory, and timing criteria.

Global demand for second-hand pharmaceutical plants

Pharmaceutical and biopharma companies around the world rely on IPP to source closed facilities that support drug production, API synthesis, biologics, and packaging. Buyers include contract manufacturers, CDMOs, and generics producers seeking a faster, lower-cost path to market.

Common systems sold in closed pharma facilities

• Stainless steel and glass-lined reactors
• Vacuum tray and freeze dryers
• API process and crystallization lines
• Clean-in-place (CIP) systems
• Filter dryers and centrifuges
• HVAC and cleanroom components

Benefits of selling your closed pharmaceutical plant with IPP             

• Get fast access to motivated, qualified buyers
• Eliminate holding costs and security risks
• Avoid auctions and preserve asset value
• Reduce decommissioning timelines
• Access experts in pharma-grade resale and logistics
• Optional support for site remediation and reuse

A closed pharma plant doesn’t need to sit idle. IPP can help you exit fast, recover value, and move forward — with confidence and compliance. Contact us today to get started.

Read more about the world’s largest seller of process plants and equipment.

IPP enters agreement to market BASF ammonia, methanol and melamine plants in Germany

IPP’s UGE subsidiary earns National Board ‘R’ certificate for Eastover, SC facility

Frequently asked questions about selling closed pharmaceutical plants

What types of pharma plants does IPP help sell?

We support the sale of bulk API, finished dose, biologics, and specialty pharmaceutical plants, with or without packaging lines.

Can you help assess asset value before listing?

Yes. We offer detailed valuation and asset audits to support internal decision-making and buyer marketing.

Does IPP understand cGMP and compliance needs?

Absolutely. We’ve handled hundreds of pharmaceutical plant divestments and know how to maintain compliance and data integrity throughout the process.

Do you sell to buyers outside the U.S.?

Yes. Our buyer base spans more than 100 countries, especially in India, Europe, South America, and Southeast Asia.

Can buyers purchase the full facility or just specific systems?

Both options are possible. Some buyers want turnkey plants; others seek individual systems. IPP will align your assets to the right buyer profile.

For more answers, visit our FAQs page.